Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Connie Hess

Concepts (246)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Peripheral Arterial Disease
39
2023
380
11.510
 Why?
Percutaneous Coronary Intervention
22
2021
444
4.750
 Why?
Coronary Artery Disease
15
2020
607
4.490
 Why?
Myocardial Infarction
18
2023
927
4.190
 Why?
Lower Extremity
18
2023
335
4.100
 Why?
Platelet Aggregation Inhibitors
24
2023
401
3.550
 Why?
Fibrinolytic Agents
9
2022
234
3.060
 Why?
Endovascular Procedures
7
2023
269
3.020
 Why?
Radial Artery
9
2019
66
2.730
 Why?
Purinergic P2Y Receptor Antagonists
8
2018
62
2.480
 Why?
Acute Coronary Syndrome
7
2023
253
2.340
 Why?
Vascular Surgical Procedures
6
2021
259
2.190
 Why?
Aspirin
13
2023
324
2.000
 Why?
Rivaroxaban
12
2023
211
2.000
 Why?
Ischemia
9
2023
362
1.830
 Why?
Stroke
10
2022
1022
1.630
 Why?
Femoral Artery
8
2023
167
1.570
 Why?
Treatment Outcome
40
2023
9088
1.560
 Why?
Anticoagulants
9
2023
550
1.510
 Why?
Postoperative Complications
6
2021
2128
1.470
 Why?
Hemorrhage
15
2023
620
1.470
 Why?
Drug-Eluting Stents
4
2021
62
1.430
 Why?
Anticholesteremic Agents
3
2023
128
1.360
 Why?
Hypercholesterolemia
2
2022
90
1.320
 Why?
Venous Thromboembolism
2
2023
231
1.300
 Why?
Atherosclerosis
5
2023
341
1.300
 Why?
Patient Readmission
4
2021
610
1.260
 Why?
Atrial Fibrillation
4
2017
322
1.130
 Why?
Cardiovascular Diseases
6
2023
1727
1.130
 Why?
Aged
40
2022
19074
1.090
 Why?
Disease Management
4
2021
560
1.060
 Why?
Humans
87
2023
114699
1.020
 Why?
Ticlopidine
3
2016
55
1.020
 Why?
Saphenous Vein
2
2015
31
0.950
 Why?
Graft Occlusion, Vascular
2
2015
35
0.950
 Why?
Factor Xa Inhibitors
6
2021
138
0.920
 Why?
Learning Curve
2
2015
63
0.900
 Why?
Female
51
2023
59520
0.900
 Why?
Cardiac Catheterization
3
2018
534
0.890
 Why?
Coronary Artery Bypass
2
2015
196
0.880
 Why?
Thrombosis
3
2022
298
0.870
 Why?
Middle Aged
35
2023
26738
0.870
 Why?
Pyridones
2
2015
123
0.870
 Why?
Male
45
2023
55606
0.860
 Why?
Risk Factors
23
2023
8632
0.860
 Why?
Warfarin
2
2015
135
0.850
 Why?
Sex Characteristics
3
2023
641
0.840
 Why?
Fibrin Fibrinogen Degradation Products
1
2023
80
0.830
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
4
2023
373
0.830
 Why?
Antifibrinolytic Agents
1
2023
50
0.820
 Why?
Postoperative Hemorrhage
2
2013
74
0.810
 Why?
Brain Ischemia
2
2022
299
0.790
 Why?
Coronary Vessels
3
2023
227
0.770
 Why?
Paclitaxel
2
2021
190
0.760
 Why?
Pyrazoles
2
2015
362
0.750
 Why?
Diabetes Complications
2
2021
211
0.750
 Why?
Heparin
3
2023
224
0.740
 Why?
Gout
2
2018
36
0.740
 Why?
Blood Coagulation Disorders
1
2023
197
0.720
 Why?
Hypolipidemic Agents
1
2021
86
0.720
 Why?
Angina Pectoris
2
2017
63
0.690
 Why?
Dyslipidemias
1
2021
154
0.660
 Why?
Leg
1
2021
225
0.660
 Why?
Risk Assessment
11
2021
2968
0.630
 Why?
Myocardial Revascularization
2
2016
67
0.620
 Why?
Reperfusion
1
2018
36
0.620
 Why?
Consensus
2
2017
537
0.600
 Why?
Drug Therapy, Combination
10
2023
951
0.580
 Why?
Upper Extremity
1
2018
84
0.580
 Why?
Time Factors
13
2021
6116
0.580
 Why?
Databases, Factual
2
2021
1125
0.570
 Why?
Coronary Angiography
3
2017
304
0.560
 Why?
Registries
10
2019
1768
0.550
 Why?
Medicare
4
2021
665
0.510
 Why?
Cholesterol, LDL
4
2023
307
0.500
 Why?
Acute Disease
4
2021
911
0.490
 Why?
Quality Indicators, Health Care
3
2023
287
0.480
 Why?
Societies, Medical
2
2023
664
0.480
 Why?
Coronary Disease
1
2017
348
0.460
 Why?
Recurrence
5
2020
935
0.460
 Why?
Follow-Up Studies
6
2021
4411
0.460
 Why?
Hospitals
3
2017
581
0.450
 Why?
United States
20
2023
12186
0.440
 Why?
Office Visits
1
2013
79
0.430
 Why?
Sex Factors
7
2022
1715
0.410
 Why?
Hematoma
2
2022
49
0.390
 Why?
Health Status Disparities
1
2014
200
0.380
 Why?
Aftercare
1
2013
186
0.380
 Why?
Quality of Life
3
2022
2353
0.380
 Why?
Subclavian Vein
1
2011
14
0.370
 Why?
Referral and Consultation
1
2016
635
0.370
 Why?
Subclavian Artery
1
2011
29
0.370
 Why?
Arteriovenous Fistula
1
2011
29
0.360
 Why?
Thrombocytopenia
1
2012
177
0.360
 Why?
Cardiology
2
2023
259
0.360
 Why?
Electric Countershock
1
2011
104
0.350
 Why?
Catheterization
1
2011
159
0.350
 Why?
Proportional Hazards Models
4
2021
1075
0.330
 Why?
Comorbidity
4
2020
1448
0.330
 Why?
Adenosine Diphosphate
1
2009
81
0.330
 Why?
Cardiovascular Agents
2
2022
126
0.320
 Why?
Randomized Controlled Trials as Topic
1
2014
1214
0.320
 Why?
Retrospective Studies
8
2022
12555
0.320
 Why?
Nitric Oxide Synthase Type III
1
2009
184
0.310
 Why?
Healthcare Disparities
1
2014
480
0.310
 Why?
AMP-Activated Protein Kinases
1
2009
172
0.300
 Why?
Gene Expression Regulation, Enzymologic
1
2009
270
0.300
 Why?
Peptides
1
2013
848
0.300
 Why?
Prospective Studies
7
2022
6220
0.300
 Why?
Defibrillators, Implantable
1
2011
286
0.290
 Why?
Cardiomyopathies
1
2011
298
0.290
 Why?
Vascular System Injuries
2
2019
66
0.290
 Why?
Catheterization, Peripheral
2
2019
101
0.280
 Why?
Double-Blind Method
4
2020
1660
0.270
 Why?
Cause of Death
3
2018
361
0.270
 Why?
Aged, 80 and over
7
2021
6347
0.270
 Why?
Intermittent Claudication
2
2023
108
0.250
 Why?
Neoplasms
2
2017
2097
0.250
 Why?
Ankle Brachial Index
2
2022
30
0.240
 Why?
Popliteal Artery
3
2023
57
0.240
 Why?
Endothelial Cells
1
2009
687
0.230
 Why?
Kaplan-Meier Estimate
3
2021
811
0.230
 Why?
Patient Discharge
3
2021
773
0.230
 Why?
Age Factors
4
2016
2894
0.230
 Why?
Longitudinal Studies
5
2018
2387
0.220
 Why?
Arteries
2
2022
247
0.220
 Why?
Incidence
5
2021
2313
0.220
 Why?
Thromboplastin
1
2023
71
0.210
 Why?
Myocardial Ischemia
2
2015
235
0.210
 Why?
Numbers Needed To Treat
1
2021
8
0.190
 Why?
Walking
2
2022
422
0.190
 Why?
Ulcer
1
2021
28
0.190
 Why?
Odds Ratio
2
2022
953
0.190
 Why?
Lactones
1
2022
54
0.190
 Why?
Clinical Trials as Topic
2
2017
932
0.180
 Why?
Syndrome
1
2021
333
0.180
 Why?
Cholesterol
1
2022
367
0.180
 Why?
Angioplasty, Balloon
1
2021
88
0.180
 Why?
Limb Salvage
1
2020
52
0.180
 Why?
Antineoplastic Agents, Phytogenic
1
2021
181
0.170
 Why?
Hospitalization
2
2019
1752
0.170
 Why?
Hypertension
2
2022
1056
0.170
 Why?
United Kingdom
1
2020
226
0.170
 Why?
Pharmaceutical Preparations
1
2021
165
0.160
 Why?
Secondary Prevention
1
2020
222
0.160
 Why?
Extremities
1
2020
113
0.160
 Why?
Aorta
1
2021
386
0.160
 Why?
Receptors, Purinergic P2Y12
1
2018
6
0.160
 Why?
Platelet Glycoprotein GPIIb-IIIa Complex
1
2018
22
0.160
 Why?
Cohort Studies
2
2022
4895
0.160
 Why?
Pyridines
1
2022
425
0.150
 Why?
Exercise Therapy
1
2022
352
0.150
 Why?
Antithrombins
1
2018
49
0.150
 Why?
Stents
3
2020
475
0.150
 Why?
Non-ST Elevated Myocardial Infarction
1
2017
16
0.150
 Why?
Practice Guidelines as Topic
2
2017
1395
0.150
 Why?
American Heart Association
3
2023
264
0.140
 Why?
Plaque, Atherosclerotic
1
2017
44
0.140
 Why?
ST Elevation Myocardial Infarction
1
2017
50
0.140
 Why?
Intraoperative Complications
1
2017
122
0.130
 Why?
Mortality
1
2018
287
0.130
 Why?
Uric Acid
1
2017
148
0.130
 Why?
Antibodies, Monoclonal
2
2023
1262
0.130
 Why?
Blood Platelets
1
2018
351
0.130
 Why?
North Carolina
1
2015
97
0.120
 Why?
Hospital Bed Capacity
1
2014
21
0.120
 Why?
Smoking
1
2022
1383
0.120
 Why?
Hospitals, Low-Volume
1
2014
22
0.120
 Why?
Hospitals, High-Volume
1
2014
39
0.120
 Why?
Clinical Trials Data Monitoring Committees
1
2014
5
0.120
 Why?
Vascular Patency
1
2014
97
0.120
 Why?
Prosthesis Design
2
2017
285
0.110
 Why?
Diabetes Mellitus
1
2022
900
0.110
 Why?
Diagnosis-Related Groups
1
2013
26
0.110
 Why?
Survivors
1
2017
411
0.110
 Why?
Professional Competence
1
2014
81
0.110
 Why?
Logistic Models
1
2018
1841
0.110
 Why?
Guideline Adherence
1
2017
490
0.110
 Why?
Antibodies, Monoclonal, Humanized
1
2017
663
0.110
 Why?
Practice Patterns, Physicians'
2
2018
1177
0.110
 Why?
Fee-for-Service Plans
1
2013
83
0.110
 Why?
Inflammation
1
2023
2480
0.100
 Why?
Platelet Factor 4
1
2012
21
0.100
 Why?
Infusions, Intravenous
1
2013
371
0.100
 Why?
Heart Failure
2
2016
1945
0.100
 Why?
Prognosis
2
2021
3329
0.090
 Why?
Radiography, Interventional
1
2011
104
0.090
 Why?
Hospital Mortality
1
2014
776
0.080
 Why?
Naphthalimides
1
2009
2
0.080
 Why?
Calcium-Calmodulin-Dependent Protein Kinase Kinase
1
2009
3
0.080
 Why?
Heart Diseases
1
2013
331
0.080
 Why?
Predictive Value of Tests
1
2014
1796
0.080
 Why?
Sensitivity and Specificity
1
2013
1693
0.080
 Why?
Communication
1
2014
744
0.080
 Why?
Benzimidazoles
1
2009
138
0.080
 Why?
Protein Isoforms
1
2009
338
0.080
 Why?
Case-Control Studies
1
2015
3003
0.080
 Why?
Combined Modality Therapy
2
2021
1121
0.070
 Why?
Enzyme Activation
1
2009
785
0.070
 Why?
Phosphatidylinositol 3-Kinases
1
2009
329
0.070
 Why?
Clinical Competence
1
2014
893
0.070
 Why?
Quality Improvement
1
2014
950
0.070
 Why?
Cattle
1
2009
920
0.070
 Why?
Young Adult
1
2021
10471
0.070
 Why?
Cell Movement
1
2009
869
0.060
 Why?
Phosphorylation
1
2009
1569
0.060
 Why?
Autoantibodies
1
2012
1346
0.060
 Why?
Subtilisin
1
2023
3
0.050
 Why?
Prevalence
2
2021
2251
0.050
 Why?
Proprotein Convertases
1
2023
14
0.050
 Why?
Lipoprotein(a)
1
2023
51
0.050
 Why?
Adolescent
1
2021
17853
0.050
 Why?
Proprotein Convertase 9
1
2023
61
0.050
 Why?
Diabetes Mellitus, Type 2
1
2016
2096
0.050
 Why?
Mobility Limitation
1
2022
60
0.050
 Why?
Public Health Surveillance
1
2021
61
0.050
 Why?
Coated Materials, Biocompatible
1
2021
54
0.050
 Why?
Diagnostic Tests, Routine
1
2021
87
0.040
 Why?
Adult
1
2021
30553
0.040
 Why?
Internationality
1
2020
143
0.040
 Why?
Disease Susceptibility
1
2021
316
0.040
 Why?
Advisory Committees
1
2021
208
0.040
 Why?
Punctures
1
2019
36
0.040
 Why?
Global Health
1
2021
287
0.040
 Why?
Reoperation
1
2021
514
0.040
 Why?
Drug Utilization Review
1
2017
57
0.040
 Why?
Health Care Costs
1
2021
381
0.040
 Why?
Socioeconomic Factors
1
2021
1079
0.040
 Why?
Dose-Response Relationship, Drug
1
2021
1842
0.030
 Why?
Surgery, Computer-Assisted
1
2017
62
0.030
 Why?
Signal Transduction
1
2009
4515
0.030
 Why?
Comparative Effectiveness Research
1
2017
130
0.030
 Why?
Chi-Square Distribution
1
2017
493
0.030
 Why?
Drug Prescriptions
1
2017
239
0.030
 Why?
Patient Selection
1
2019
641
0.030
 Why?
Platelet Function Tests
1
2015
24
0.030
 Why?
Administration, Oral
1
2017
728
0.030
 Why?
Early Termination of Clinical Trials
1
2014
14
0.030
 Why?
Mass Screening
1
2021
1005
0.030
 Why?
Multivariate Analysis
1
2017
1430
0.030
 Why?
Retreatment
1
2013
67
0.030
 Why?
Canada
1
2014
322
0.030
 Why?
Patient Preference
1
2014
167
0.030
 Why?
Linear Models
1
2014
768
0.020
 Why?
Pregnancy
1
2023
5520
0.020
 Why?
Animals
1
2009
31708
0.020
 Why?
Hess's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (246) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)